Our President, Rick Anderson, speaks with Modern Healthcare on the challenges facing prescription digital therapeutics and why there are better options for commercializing proven solutions. To learn more, visit: ow.ly/WymS50NLC10

Studies like this are one of the many reasons we value our partner, Sanofi US. Congratulations to the research team at Sanofi and our clinical leadership Omar Manejwala, M.D. and Yifat Fundoiano-Hershcovitz on the release of this important data. Learn more: ow.ly/ffkW50Ojful

Incredible research from our partners at Sanofi demonstrating the value of Dario in helping to reduce high-cost health care utilization for our clients. Our highly personalized solutions are proven to deliver better outcomes - and now we have clinically r…lnkd.in/d6gUpPXY

#DarioHealth announced today that Sanofi #research demonstrates 9.3% reduction in all-cause #healthcare resource utilization rates, including 23.5% decrease in hospitalization. dariohealth.investorroom.com/2023-05-09-San…

#DarioHealth #diabetes Solution is a #digital #health application for type 2 diabetes mellitus management. It combines a blood #glucose meter and a mobile app, allowing patients to track BG levels in real-time. ispor.org/heor-resources…

Our Chief Medical Officer, Omar Manejwala, M.D., comments on new research released at ISPOR by our partner Sanofi. Amazing effort from all who helped propel this research forward. To learn more about the research, read: ow.ly/aR5n50OjRy7

We were excited for this research to be presented at ISPOR on Monday. This is the first of many data points to be released from this important, highly rigorous analysis of digital health. To learn more, visit: ow.ly/gnCz50OkxIu

$DRIO - DarioHealth GAAP EPS of -$0.45 beats by $0.05, revenue of $7.07M beats by $0.37M seekingalpha.com/news/3969870-d…

DarioHealth™ is excited to announce a new agreement with MedOne Pharmacy Benefit Solutions to deliver Dario's suite of digital health solutions as a complement to their Diabetes Care Path. The launch marks a major milestone achievement with our partner, Sanofi US. ow.ly/a0ku50Or4G4

As part of our commitment to ensuring comprehensive #diabetes care is accessible in low- and middle-income countries and underserved communities worldwide, we are teaming up with MOH-Ghana for a three-year program. Check out this short video about our shared ambition

Obesity treatment options are exploding and ADA’s Scientific Sessions will highlight the expanding universe of incretins- new clinical trials on high dose oral GLP-1 to dual agonists and even triple agonists - CAN’T WAIT! professional.diabetes.org/scientific-ses… American Diabetes Association - DiabetesPro #ADA2023

DarioHealth™ is excited to announce that two new full-suite employer contracts will launch in the second half of 2023. The new accounts selected Dario for the ease of a single, integrated solution. To learn more, visit: ow.ly/7gQR50OHXfN

The #DarioHealth team was excited to support the JED (JED) last night at their annual gala. #JEDGala2923 empowers teens & young adults by equipping them to build resiliency, life skills, promoting social connectedness & encouraging them to seek & give help when needed

Our President, Rick Anderson, was featured in a recent article by Modern Healthcare exploring the current DTX environment and shared his perspective on avenues to success for other DTX companies. To read the article, subscribe to Modern Healthcare and visit: ow.ly/KNFs50OOqJ7

Dario is on the leading edge of DTx. With GLP-1, AI and Behavioral Health making headlines, Dario has the integrated solution. Obesity costs the US $173 billion annually, Dario brings data-driven insights to obesity management.

Marizyme just received FDA clearance for its flagship product, Duragraft. Duragraft's unique advantages have the potential to establish a new standard of care for the 500,000+ #coronarybypass surgeries performed in the US each year. investors.marizyme.com/news/news-deta…

Exxon 2050 Forecast bucks the trend img1.wsimg.com/blobby/go/5f4a…